IFP Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $308K | Buy |
585
+52
| +10% | +$29.2K | 0.01% | 1277 |
|
|
2026
Q1 | $299K | Buy |
533
+270
| +103% | +$173K | 0.01% | 1199 |
|
|
2025
Q4 | $178K | Sell |
263
-112
| -30% | -$76.3K | ﹤0.01% | 1435 |
|
|
2025
Q3 | $240K | Sell |
375
-217
| -37% | -$132K | 0.01% | 1200 |
|
|
2025
Q2 | $318K | Sell |
592
-274
| -32% | -$131K | 0.01% | 1040 |
|
|
2025
Q1 | $364K | Sell |
866
-37
| -4% | -$16.1K | 0.01% | 897 |
|
|
2024
Q4 | $373K | Buy |
903
+31
| +4% | +$13.6K | 0.01% | 855 |
|
|
2024
Q3 | $440K | Sell |
872
-271
| -24% | -$132K | 0.02% | 738 |
|
|
2024
Q2 | $557K | Buy |
1,143
+638
| +126% | +$320K | 0.02% | 622 |
|
|
2024
Q1 | $273K | Buy |
505
+85
| +20% | +$46.5K | 0.01% | 850 |
|
|
2023
Q4 | $233K | Buy |
420
+279
| +198% | +$131K | 0.01% | 877 |
|
|
2023
Q3 | $61.7K | Sell |
141
-316
| -69% | -$158K | ﹤0.01% | 1465 |
|
|
2023
Q2 | $230K | Sell |
457
-204
| -31% | -$97.8K | 0.01% | 956 |
|
|
2023
Q1 | $142K | Sell |
661
-694
| -51% | -$332K | 0.01% | 1086 |
|
|
2022
Q4 | $313K | Buy |
1,355
+4
| +0.3% | +$1.55K | 0.01% | 1122 |
|
|
2022
Q3 | $326K | Buy |
1,351
+210
| +18% | +$77.1K | 0.01% | 1149 |
|
|
2022
Q2 | $279K | Hold |
1,141
| – | – | 0.01% | 1113 |
|
|
2022
Q1 | $279K | Buy |
1,141
+920
| +416% | +$484K | 0.01% | 1113 |
|
|
2021
Q4 | $146K | Buy |
221
+123
| +126% | +$77.2K | ﹤0.01% | 1101 |
|
|
2021
Q3 | $62K | Buy |
98
+15
| +18% | +$10.1K | ﹤0.01% | 1498 |
|
|
2021
Q2 | $54K | Buy |
83
+5
| +6% | +$2.76K | ﹤0.01% | 1489 |
|
|
2021
Q1 | $36K | Sell |
78
-42
| -35% | -$21K | ﹤0.01% | 1590 |
|
|
2020
Q4 | $56K | Buy |
120
+81
| +208% | +$36.2K | ﹤0.01% | 1395 |
|
|
2020
Q3 | $14K | Buy |
39
+6
| +18% | +$2.22K | ﹤0.01% | 1779 |
|
|
2020
Q2 | $11K | Sell |
33
-21
| -39% | -$6.08K | ﹤0.01% | 1785 |
|
|
2020
Q1 | $13K | Sell |
54
-9
| -14% | -$2.35K | ﹤0.01% | 1666 |
|
|
2019
Q4 | $16K | Sell |
63
-154
| -71% | -$40.6K | ﹤0.01% | 1719 |
|
|
2019
Q3 | $58K | Buy |
+217
| New | +$60.4K | ﹤0.01% | 1301 |
|
|
2019
Q1 | $58K | Sell |
264
-178
| -40% | -$36.7K | 0.01% | 903 |
|
|
2018
Q4 | $82K | Sell |
442
-495
| -53% | -$101K | 0.01% | 1306 |
|
|
2018
Q3 | $234K | Buy |
937
+537
| +134% | +$130K | 0.01% | 993 |
|
|
2018
Q2 | $87K | Sell |
400
-62
| -13% | -$12.8K | ﹤0.01% | 1556 |
|
|
2018
Q1 | $72K | Hold |
462
| – | – | ﹤0.01% | 1582 |
|
|
2017
Q4 | $72K | Sell |
462
-156
| -25% | -$24.6K | ﹤0.01% | 1594 |
|
|
2017
Q3 | $96K | Sell |
618
-53
| -8% | -$8.38K | ﹤0.01% | 1585 |
|
|
2017
Q2 | $108K | Sell |
671
-534
| -44% | -$86.7K | ﹤0.01% | 1490 |
|
|
2017
Q1 | $186K | Sell |
1,205
-46
| -4% | -$6.34K | 0.01% | 1155 |
|
|
2016
Q4 | $147K | Buy |
1,251
+69
| +6% | +$7.87K | 0.01% | 1212 |
|
|
2016
Q3 | $133K | Sell |
1,182
-21
| -2% | -$2.21K | 0.01% | 1207 |
|
|
2016
Q2 | $112K | Buy |
1,203
+939
| +356% | +$80.6K | 0.01% | 1260 |
|
|
2016
Q1 | $58K | Sell |
264
-709
| -73% | -$51.1K | 0.01% | 903 |
|
|
2015
Q4 | $71K | Buy |
+973
| New | +$69.4K | ﹤0.01% | 1380 |
|
Other funds holding IDXX
IFP Advisors's IDXX Position: Q2 2026 in Review
IFP Advisors increased its Idexx Laboratories (IDXX) stake by 9.8% in Q2 2026, buying an estimated $29.2K and bringing the position to 585 shares worth $308K. The position accounts for 0.01% of the portfolio, ranked #1277.
IFP Advisors first reported a position in IDXX in Q4 2015 and has held it in 42 quarters since. The position peaked at $557K in Q2 2024. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- IFP Advisors held 585 shares of Idexx Laboratories worth $308K as of Q2 2026.
- IFP Advisors bought 52 Idexx Laboratories shares in Q2 2026, an estimated $29.2K.
- Idexx Laboratories made up 0.01% of IFP Advisors's portfolio in Q2 2026, its #1277 holding.
- IFP Advisors first reported a position in Idexx Laboratories in Q4 2015 and has held it in 42 quarters since.
- IFP Advisors's Idexx Laboratories position peaked at $557K in Q2 2024.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.